We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trichloroethylene (TCE) Exposure in an Industrial Population (TCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00839514
Recruitment Status : Completed
First Posted : February 9, 2009
Last Update Posted : June 7, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study is to follow-up with workers from a local company that had exposure to TCE that may have symptoms of Parkinson's disease. We hope to learn more about TCE exposure and Parkinson's disease. Eligible participants will be those who participated in previous research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"

Condition or disease
Parkinson's Disease

Study Design

Study Type : Observational
Actual Enrollment : 27 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Evaluation of Parkinson Disease Symptoms in Trichloroethylene Exposed Patients in an Industrial Population
Study Start Date : February 2009
Primary Completion Date : August 2009
Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Follow-up with individuals who previously particpated in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"
Criteria

Inclusion Criteria:

  • Previous participant in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"

Exclusion Criteria:

  • Not a participant in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00839514


Locations
United States, Kentucky
University of Kentucky
Lexington, Kentucky, United States, 40536-0284
Sponsors and Collaborators
University of Kentucky
Investigators
Principal Investigator: John T Slevin, MD University of Kentucky
More Information

Publications:
Responsible Party: John Slevin, Principal investigator, University of Kentucky
ClinicalTrials.gov Identifier: NCT00839514     History of Changes
Other Study ID Numbers: 08-0301
First Posted: February 9, 2009    Key Record Dates
Last Update Posted: June 7, 2012
Last Verified: June 2012

Keywords provided by John Slevin, University of Kentucky:
Parkinson's disease
Trichloroethylene

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Trichloroethylene
Anesthetics, Inhalation
Anesthetics, General
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs